SCHEMBL4497582

SCHEMBL4497582

COc1c(Cl)cc(OCc2ccccc2)cc1C=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 1/20 0.50
ERN1 O75460 3/20 0.47
MAOB P27338 3/20 0.47
MAOA P21397 1/20 0.47
LMNA P02545 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGD P15428 1/20 0.42
S1PR1 P21453 1/20 0.40
PRKX P51817 1/20 0.40
ACVR1 Q04771 1/20 0.40
S1PR5 Q9H228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536318 0.85 TUBB1 (0.51) TUBB1ERN1MAOBMAOALMNA
SCHEMBL4515720 0.83 MAPT (0.52) MAOBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL4515723 0.83 MAPT (0.52) MAOBLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL23796751 0.82 MAOB (0.57) TUBB1ERN1MAOBMAOALMNA
SCHEMBL20815159 0.82 TUBB1 (0.58) TUBB1ERN1MAOBMAOAMEN1
SCHEMBL190184 0.79 HPGD (0.58) MAOBMAOAMEN1KMT2ASMN1; SMN2
SCHEMBL30402795 0.79 MAOA (0.56) MAOBMAOAMEN1KMT2ASMN1; SMN2
SCHEMBL28626686 0.79 TUBB1 (0.40) TUBB1ERN1ALDH1A1TDP1
SCHEMBL4079311 0.79 MAOA (0.56) MAOBMAOAMEN1KMT2ASMN1; SMN2
SCHEMBL210293 0.78 MAOA (0.55) MAOBMAOALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042957-A1 Substituted Oxyarenes BAYER CROPSCIENCE AG (DE) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042957-A1 Substituted Oxyarenes CYP1A1, OXER1, CYP1A2 TUBB1 1449/4885ERN1 539/4885MAOB 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.